Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

• المؤلفون الرئيسيون: Schwartz, GG, Szarek, M, Bittner, VA, Diaz, R, Goodman, SG, Jukema, JW, Landmesser, U, López-Jaramillo, P, Manvelian, G, Pordy, R, Scemama, M, Sinnaeve, PR, White, HD, Gabriel Steg, P, Gabriel Steg, PH, Bhatt, DL, Harrington, RA, Zeiher, AM, Tricoci, P, Roe, MT, Mahaffey, KW, Edelberg, JM, Hanotin, C, Lecorps, G, Moryusef, A, Sasiela, WJ, Tamby, JF, Aylward, PE, Drexel, H, Sinnaeve, P, Dilic, M, Lopes, RD, Gotcheva, NN, Prieto, JC, Yong, H, Pećin, I, Reiner, Z, Ostadal, P, Poulsen, SH, Viigimaa, M, Nieminen, MS, Danchin, N, Chumburidze, V, Marx, N, Liberopoulos, E, Montenegro Valdovinos, PC, Tse, HF, Kiss, RG, Xavier, D, Zahger, D, Valgimigli, M, Kimura, T, Kim, HS, Kim, SH, Erglis, A, Laucevicius, A, Kedev, S, Yusoff, K, Ramos López, GA, Alings, M, Halvorsen, S, Correa Flores, RM, Sy, RG, Budaj, A, Morais, J, Dorobantu, M, Karpov, Y, Ristic, AD, Chua, T, Murin, J, Fras, Z, Dalby, AJ, Tuñón, J, Asita de Silva, H, Hagström, E, Müller, C, Chiang, CE, Sritara, P, Guneri, S, Parkhomenko, A, Ray, KK, Moriarty, PM, Vogel, R, Chaitman, B, Kelsey, SF, Olsson, AG, Rouleau, JL, Simoons, ML, Alexander, K, Meloni, C, Rosenson, R, Sijbrands, EJG, Alexander, JH, Armaganijan, L, Bagai, A, Bahit, MC, Brennan, JM, Clifton, S, DeVore, AD, Deloatch, S
• مؤلفون آخرون: MEDICINE
• التنسيق: مقال
• منشور في: Elsevier BV 2022
• الموضوعات: PCSK9 inhibitor; acute coronary syndrome; lipoprotein(a); low-density lipoprotein cholesterol; Acute Coronary Syndrome; Aged; Antibodies, Monoclonal, Humanized; Cardiovascular Diseases; Cholesterol, LDL; Female; Humans; Lipoprotein(a); Male; Middle Aged; PCSK9 Inhibitors
• الوصول للمادة أونلاين: https://scholarbank.nus.edu.sg/handle/10635/228830

10.1016/j.jacc.2021.04.102